155 related articles for article (PubMed ID: 8387696)
1. Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon.
Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E; Yoshizawa K; Furuta K; Nakatsuji Y; Urushihara A; Furuta S
Scand J Gastroenterol; 1993 Apr; 28(4):335-42. PubMed ID: 8387696
[TBL] [Abstract][Full Text] [Related]
2. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
[TBL] [Abstract][Full Text] [Related]
3. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
Urushihara A; Sodeyama T; Matsumoto A; Tanaka E
J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
[TBL] [Abstract][Full Text] [Related]
4. Short and long-term effects of interferon on serum markers of hepatitis C virus replication.
Yatsuhashi H; Inoue O; Inokuchi K; Koga M; Nagataki S; Cha TA; Irvine B; Stempien M; Kolberg J; Urdea MS
J Gastroenterol Hepatol; 1993; 8(1):1-6. PubMed ID: 8382537
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.
Diodati G; Bonetti P; Tagger A; Casarin C; Noventa F; Ribero M; Fasola M; Ruol A; Realdi G
Dig Dis Sci; 1994 Nov; 39(11):2497-502. PubMed ID: 7525169
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S
Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249
[TBL] [Abstract][Full Text] [Related]
7. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
[TBL] [Abstract][Full Text] [Related]
8. Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study.
Brillanti S; Garson JA; Tuke PW; Ring C; Briggs M; Masci C; Miglioli M; Barbara L; Tedder RS
J Med Virol; 1991 Jun; 34(2):136-41. PubMed ID: 1716296
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
Oketani M; Tanaka K; Sho Y; Maeda E; Miyazaki H; Arima T
Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
[TBL] [Abstract][Full Text] [Related]
10. Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease.
Hayashi J; Nakashima K; Kishihara Y; Ohmiya M; Yoshimura E; Hirata M; Kashiwagi S
J Infect; 1993 May; 26(3):287-94. PubMed ID: 7685043
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to hepatitis C virus and hepatitis C virus infection.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Fusamoto H; Kamada T
Gastroenterol Jpn; 1993 May; 28 Suppl 5():76-9. PubMed ID: 7689512
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.
Quiroga JA; Bosch O; Gonzalez R; Marriott E; Castillo I; Bartolome J; Carreño V
Gastroenterology; 1992 Oct; 103(4):1285-9. PubMed ID: 1383071
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of reactivity to individual epitopes of the hepatitis C viral genome.
Yatsuhashi H; Inokuchi K; Inoue O; Matsumura N; Koga M; Kosakai Y; Yano M
Gastroenterol Jpn; 1993 May; 28 Suppl 5():6-11. PubMed ID: 7689509
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term-studied patients with posttransfusion hepatitis C.
Mattsson L; Gutierrez RA; Dawson GJ; Lesniewski RR; Mushahwar LK; Weiland O
Scand J Gastroenterol; 1991 Dec; 26(12):1257-62. PubMed ID: 1722348
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients.
Yoshida CF; Takahashi Y; Vanderborght BO; Rouzere CD; França MS; Takahashi C; Takamizawa A; Yoshida I; Schatzmayr HG
Rev Inst Med Trop Sao Paulo; 1993; 35(4):315-21. PubMed ID: 7509506
[TBL] [Abstract][Full Text] [Related]
17. [Changes in C100-3, and N14 antibodies in patients with chronic hepatitis C treated with interferon].
Sakurai K; Yagi K; Hanawa Y; Shibuya A; Shibata H; Uchiyama Y; Ohtani H
Rinsho Byori; 1994 Feb; 42(2):171-5. PubMed ID: 7511184
[TBL] [Abstract][Full Text] [Related]
18. Improved serodiagnosis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens.
Wang JT; Wang TH; Lin JT; Sheu JC; Lee CZ; Chen DS
Vox Sang; 1992; 62(1):21-4. PubMed ID: 1374579
[TBL] [Abstract][Full Text] [Related]
19. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C as the cause of chronic non-A, non-B hepatitis: high sensitivity of simultaneous measurement of core and non-structural antibodies.
Lin R; Yatuhashi H; Yano M; Farrell GC
J Gastroenterol Hepatol; 1992; 7(5):459-62. PubMed ID: 1382656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
